Kempenhaeghe

Heeze 13 trials 6 recruiting

13 Registered trials

6 Currently recruiting

Organisation

Kempenhaeghe

Location

Heeze, Netherlands

Identifier

ORG-100044082

Address

Sterkselseweg 65, 5591 VE, Netherlands

Departments

epilepsie
NA
Neurology
Pediatric Neurology
Sleep Medicine Centre

Clinical trials at this site (13)

Search interface

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 Pending

2025-523911-13-00 Narcolepsy Type 1 5
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 Pending

2025-523912-35-00 Narcolepsy Type 2 5
Cannabidiol in refractory childhood epilepsy, a personalized high-quality approach Recruiting

2023-507843-12-01 Refractory Epilepsy 5 2025-01-24
A randomized study of XEN1101 versus placebo in Primary Generalised Tonic Clonic Seizures (X-ACKT) Recruiting

2022-502286-16-00 Primary Generalized Tonic-Clonic Seizures 5 2023-10-27
A study to determine if BHV-7000 is safe in adults with refractory focal onset epilepsy Recruiting

2023-508813-18-00 Refractory Focal Onset Epilepsy 4 2024-12-18
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Recruiting

2023-508539-30-00 Refractory Focal Onset Epilepsy 4 2024-10-10
An Open-label Study of XEN1101 in Epilepsy Recruiting

2022-502282-24-00 Primary generalized tonic-clonic seizures 5 2024-02-14
Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) Recruiting

2022-502281-25-00 Focal Onset Seizures 5 2023-09-27
Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Idiopathic Generalized Epilepsy with Generalized Tonic-clonic Seizures – SHIN… Ended

2023-508812-45-00 Idiopathic Generalized Epilepsy with Generalized Tonic- 10 2024-11-11
The CanISleepinMS Study Ended

2024-518280-35-00 Insomnia 4 2024-03-26
Open-label extesnion study of soticlestat in Dravet and Lennox-Gastaut Syndromes Ended

2022-502802-34-00 Dravet and Lennox-Gastaut Syndromes 5 2022-04-05
EQU-001 as an Add-On Drug for People with Focal Seizures while on Medication Ended

2022-500302-18-00 Epilepsy 4
The ENACT Trial: A Randomized, double-blind, placebo-controlled adjunctive treatment trial to evaluate the efficacy and safety of ENX-101 in… Expired

2022-501028-95-00 focal (partial onset) epilepsy 4